Exelixis
EXEL
363 hedge funds and large institutions have $5.45B invested in Exelixis in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 133 increasing their positions, 126 reducing their positions, and 56 closing their positions.
305% more call options, than puts
Call options by funds: $48.8M | Put options by funds: $12.1M
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
23% more capital invested
Capital invested by funds: $4.42B → $5.45B (+$1.02B)
6% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 126
0.33% less ownership
Funds ownership: 86.9% → 86.57% (-0.33%)
6% less funds holding
Funds holding: 386 → 363 (-23)
30% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 56
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$123M |
| 2 |
JP Morgan Chase
New York
|
-$82.9M |
| 3 |
Goldman Sachs
New York
|
-$58.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$53M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$41.3M |
EXEL Hedge Fund Activity: Q1 2023 in Review
363 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q1 2023, worth a combined $5.45B — up 23% from $4.42B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of EXEL and 39 opened new positions — a net loss of 17 holders — while 126 trimmed existing stakes and 133 added.
The largest buyer was Farallon Capital Management, adding an estimated $219M. The largest seller was Fidelity Investments, cutting an estimated $123M.
- 363 institutional investors held Exelixis (EXEL) as of Q1 2023, down from 386 in Q4 2022.
- Funds reported $5.45B of Exelixis stock for Q1 2023, up 23% quarter-over-quarter.
- 39 funds opened new Exelixis positions in Q1 2023 and 56 closed out, a net change of -17 holders.
- The largest Exelixis buyer in Q1 2023 was Farallon Capital Management, an estimated $219M added.
- The largest Exelixis seller in Q1 2023 was Fidelity Investments, an estimated $123M sold.
Based on aggregated 13F filings for Q1 2023.